KIAA1199 and Its Role in Colon Cancer
Author Information
Author(s): Birkenkamp-Demtroder K, Maghnouj A, Mansilla F, Thorsen K, Andersen C L, Øster B, Hahn S, Ørntoft T F
Primary Institution: Aarhus University Hospital/Skejby
Hypothesis
The study aims to characterize the KIAA1199 transcript and protein expression in colorectal adenocarcinomas and its correlation with patient outcomes.
Conclusion
KIAA1199 knockdown reduces Wnt/β-catenin signaling and may serve as a regulatory component of this pathway in colon cancer.
Supporting Evidence
- KIAA1199 was strongly upregulated in 95% of colon adenocarcinomas.
- Knockdown of KIAA1199 reduced cellular proliferation by about 50%.
- High KIAA1199 expression correlated with better outcomes in a subgroup of patients.
Takeaway
KIAA1199 is a protein that helps colon cancer cells grow, and when it's turned off, the cancer cells grow slower.
Methodology
The study involved transcript profiling, methylation profiling, and immunohistochemistry on colon cancer samples.
Potential Biases
Potential biases in sample selection and analysis methods.
Limitations
The study focused on specific stages of colorectal cancer and may not generalize to all cancer types.
Participant Demographics
The study included 270 stage II colorectal cancer patients with at least 3 years of follow-up.
Statistical Information
P-Value
p<1E-07
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website